A – please go back to the ASX announcement on 28 October 2013.
This is what JCR said (Mesoblast simply passed on JCR’s comments) :
"In an announcement to the Tokyo Securities Exchange on 24 October, JCR President and CEO Shin Ashida said the company intends to file for product regulatory approval in Japan for JR-031 during the fiscal year ending March 2014. If the filing is successful, JR-031 would be the first allogeneic cell-based product approved in Japan ".
MSB then subsequently confirmed on a number of occasions what was stated by JCR in the 24 October JCR announcement to Tokyo SEx
Not sure if you are aware,but any DIRECT updates/news flow on JR-031 ...can only be made by JCR (not MSB).
However, having said that - Mesoblast did update the market (as best they could) , as follows:
8 April 2014 Price Query:
Mesoblast collaborator, JCR Pharmaceuticals, is expanding its manufacturing facility in preparation for its commercial launch in Japan of its MSC product, JR-031. This product is being developed for the treatment of steroid-refractory graft versus host disease (GVHD) in children and adults after a bone marrow transplant. The Japanese Ministry of Health, Labour and Welfare granted JR-031 orphan drug status in December 2013 and as a result it will be subject to an expedited review. JCR has confirmed it will launch its product as scheduled in 2015.
29 April 2014 : Prochymal update.
In Japan, Mesoblast collaborator, JCR Pharmaceuticals, is expanding its manufacturing facility in preparation for its commercial launch of its MSC product, JR-031. This product was granted orphan drug status in December 2013 and as a result it will be subject to an expedited review. JCR has confirmed it will launch its product as scheduled in 2015.
Okay – I would also like to have an update1..and so would Mesoblast...but at this stage its appears JCR are full steam ahead with their plans to commercializeJR-031.
I’m Keeping it cool ...because my analysis and readings signal to me , that Mesoblast is in a mighty position to execute on a number of fronts. Continue to do DYOR , HC is a forum to share view (yours ,mine and all posters) and Good luck to anyone who has/had the opportunity to buy shares at these levels.
Best of luck to all.
A – please go back to the ASX announcement on 28 October 2013....
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |